321 related articles for article (PubMed ID: 27658388)
1. Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
Cancer Res Treat; 2017 Jul; 49(3):607-615. PubMed ID: 27658388
[TBL] [Abstract][Full Text] [Related]
2. Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999-2020.
Cho S; Park WJ
Investig Clin Urol; 2024 Jan; 65(1):23-31. PubMed ID: 38197748
[TBL] [Abstract][Full Text] [Related]
3. Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013.
Tempo J; Logan C; O'Callaghan M; Kahokehr A; Kichenadasse G; D'Onise K; Foreman D
Cancer Epidemiol; 2020 Apr; 65():101692. PubMed ID: 32151978
[TBL] [Abstract][Full Text] [Related]
4. Incidence of kidney, bladder, and prostate cancers in Korea: An update.
Song W; Jeon HG
Korean J Urol; 2015 Jun; 56(6):422-8. PubMed ID: 26078838
[TBL] [Abstract][Full Text] [Related]
5. Survey of incidence of urological cancer in South Korea: a 15-year summary.
Cheon J; Kim CS; Lee ES; Hong SJ; Cho YH; Shin EC; Lee WC; Yoon MS
Int J Urol; 2002 Aug; 9(8):445-54. PubMed ID: 12225342
[TBL] [Abstract][Full Text] [Related]
6. Increasing occurrence of urological cancers in Slovakia.
Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A
Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune disease and subsequent urological cancer.
Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
[TBL] [Abstract][Full Text] [Related]
8. Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.
Maruthappu M; Barnes I; Sayeed S; Ali R
BMC Cancer; 2015 Oct; 15():753. PubMed ID: 26486598
[TBL] [Abstract][Full Text] [Related]
9. Nationwide Trends in the Incidence and Survival of Eyelid Skin Cancers in Korea.
Jung SK; Lim J; Yang SW; Jee D; Won YJ
Ophthalmic Epidemiol; 2020 Dec; 27(6):438-448. PubMed ID: 32486892
[TBL] [Abstract][Full Text] [Related]
10. [Incidence and mortality of urological cancers in 2012 in France].
Rébillard X; Grosclaude P; Leone N; Velten M; Coureau G; Villers A; Irani J; Lebret T; Rigaud J; Pfister C; Patard JJ; Richaud P; Salomon L; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S57-65. PubMed ID: 24485294
[TBL] [Abstract][Full Text] [Related]
11. Trends in major cancer mortality in Korea, 1983-2012, with a joinpoint analysis.
Lim D; Ha M; Song I
Cancer Epidemiol; 2015 Dec; 39(6):939-46. PubMed ID: 26523983
[TBL] [Abstract][Full Text] [Related]
12. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.
Jung KW; Won YJ; Oh CM; Kong HJ; Lee DH; Lee KH;
Cancer Res Treat; 2017 Apr; 49(2):292-305. PubMed ID: 28279062
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Survival of Childhood Cancer in Korea.
Park HJ; Moon EK; Yoon JY; Oh CM; Jung KW; Park BK; Shin HY; Won YJ
Cancer Res Treat; 2016 Jul; 48(3):869-82. PubMed ID: 26790965
[TBL] [Abstract][Full Text] [Related]
14. Cancer Incidence and Survival among Adolescents and Young Adults in Korea: An Update for 2016.
Park M; Lim J; Lee JA; Park BK; Jung KW; Won YJ; Park HJ
Cancer Res Treat; 2021 Jan; 53(1):32-44. PubMed ID: 33017883
[TBL] [Abstract][Full Text] [Related]
15. Risk of urinary tract cancers following kidney or ureter stones.
Chow WH; Lindblad P; Gridley G; Nyrén O; McLaughlin JK; Linet MS; Pennello GA; Adami HO; Fraumeni JF
J Natl Cancer Inst; 1997 Oct; 89(19):1453-7. PubMed ID: 9326915
[TBL] [Abstract][Full Text] [Related]
16. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
17. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012.
Lee SH; Jung KW; Ha J; Oh CM; Kim H; Park HJ; Yoo H; Won YJ
Cancer Res Treat; 2017 Apr; 49(2):494-501. PubMed ID: 27554477
[TBL] [Abstract][Full Text] [Related]
18. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
19. [Trends in urologic neoplasm mortality and incidence (prostate, bladder, and kidney). Soria, 1950-1988].
Ruiz Liso JM; Sanz Anquela JM; Alfaro Torres J; García Pérez MA; Dodero de Solano E
Arch Esp Urol; 1989; 42(6):532-8. PubMed ID: 2817983
[TBL] [Abstract][Full Text] [Related]
20. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
